视网膜海绵状血管瘤随访21年一例

doi:10.3760/cma.j.cn115909-20200826-00343

摘要
图/表
参考文献(16)
相关文章 (15)

全文: PDF 17318KB HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

文章导读

摘要患儿，女，3岁，因“家长发现右眼斜2年”于1998年5 月 18 日至青岛眼科医院就诊。患者足月顺产，无吸氧史，无眼病家族史。眼科检查：1%阿托品眼膏散瞳 5 d验光结果显示右眼视力0.08（-3.0×180=0.1），左眼 0.25（+2.00+0.50×75=0.8），双眼眼压正常。右眼内斜 15 △～20 △，右眼内转眼位高，睑裂变小，左眼内转时睑裂也变小，头向左肩倾斜。右眼前节未见异常。眼底检查：右眼玻璃体少量出血，视盘、黄斑区正常，视网膜下方见约 6 PD×6 PD出血病灶，病灶周围视网膜散在色素沉着，视网膜在位（见图1A）。左眼未见明显异常。诊断右眼视网膜血管瘤，给予卵磷脂络合碘片促进出血吸收，配镜矫正屈光不正，建议每日遮盖左眼配合弱视训练，眼底定期复查。 2000年3月患儿至北京协和医院就诊行荧光素眼底血管造影（FFA）检查（见图2A），诊断为右眼视网膜海绵状血管瘤。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	赵中芳1 李君2 董晓光2

关键词 ：

Abstract：

Key words：

收稿日期: 2020-08-26

PACS:

基金资助:

通讯作者: 李君（ORCID：0000-0001-9121-6162），Email：doctor_li@126.com

引用本文:

赵中芳1 李君2 董晓光2. 视网膜海绵状血管瘤随访21年一例[J]. 中华眼视光学与视觉科学杂志, 2021, 23(6): 457-460.

链接本文:

https://www.cjoovs.com/CN/10.3760/cma.j.cn115909-20200826-00343 或 https://www.cjoovs.com/CN/Y2021/V23/I6/457

[1]	Niccol W, Moore RF. A case of angiomatosis retinae. Br J Ophthalmol, 1934, 18(8): 454-457. DOI: 10.1136/bjo.18.8.454.
[2]	Hewick S, Lois N, Olson JA. Circumferential peripheral retinal cavernous hemangioma. Arch Ophthalmol, 2004, 122(10): 1557- 1560. DOI: 10.1001/archopht.122.10.1557.
[3]	Gass JD. Cavernous hemangioma of the retina. A neuro-oculocutaneous syndrome. Am J Ophthalmol, 1971, 71(4): 799-814. DOI: 10.1016/0002-9394(71)90245-5.
[4]	Shields JA, Eagle RC, Ewing MQ, et al. Retinal cavernous hemangioma: Fifty-two years of clinical follow-up with clinicopathologic correlation. Retina, 2014, 34(6): 1253-125. DOI: 10.1097/IAE.0000000000000232.
[5]	Messmer E, Laqua H, Wessing A, et al. Nine cases of cavernous hemangioma of the retina. Am J Ophthalmol, 1983, 95: 383- 390. DOI: 10.1016/s0002-9394(14)78309-6.
[6]	Sarraf D, Payne AM, Kitchen ND, et al. Familial cavernous hemangioma: An expanding ocular spectrum. Arch Ophthalmol, 2000, 118(7): 969-973.
[7]	Shantan R, Michael BG, Tara AM, et al. Novel KRIT1/CCM1 mutation in a patient with retinal cavernous hemangioma and cerebral cavernous malformation. Graefes Arch Clin Exp Ophthalmol, 2010, 248(9): 1359-1361. DOI: 10.1007/s00417- 010-1329-6.
[8]	Singh E, Sen A. A case of retinal cavernous hemangioma analyzed with optical coherence tomography angiography. Indian J Ophthalmol, 2019, 67(4): 561-563. DOI: 10.4103/ijo. IJO_1478_18.
[9]	Li J, Li Y, Li H. New Interpretation of multimodality fundus imaging for retinal cavernous hemangioma. Curr Eye Res, 2019, 44(4): 423-427. DOI: 10.1080/02713683.2018.1549263.
[10]	Hasanpour H, Ramezani A, Karimi S. Recurrent vitreous hemorrhage in a case of retinal cavernous hemangioma: A rare presentation. J Ophthalmic Vis Res, 2016, 11(3): 333-335. DOI: 10.4103/2008-322X.188398.
[11]	Turell ME, Singh AD. Vascular tumors of the retina and choroid: Diagnosis and treatment. Middle East Afr J Ophthalmol, 2010, 17(3): 191-200. DOI: 10.4103/0974-9233.65486.
[12]	Pringle E, Chen S, Rubinstein A, et al. Optical coherence tomography in retinal cavernous haemangioma may explain the mechanism of vitreous haemorrhage. Eye (Lond), 2009, 23(5): 1242-1243. DOI: 10.1038/eye.2008.156.
[13]	Gilda Cennamo, Francesca Amoroso, Domenico Solari, et al. Optical coherence tomography angiography in retinal cavernous hemangioma. Int J Ophthalmol, 2017, 10(12): 1945-1946. DOI: 10.18240/ijo.2017.12.27.
[14]	Shuyuan Lyu, Ming Zhang, Ruikang K Wang, et al. Eye Clinic, Department of Public Health, University of Naples Federico II, Naples 80100, IAnalysis of the characteristics of optical coherence tomography angiography for retinal cavernous hemangioma. Medicine (Baltimore), 2018, 97(7): e9940. DOI: 10.1097/MD.0000000000009940.
[15]	Japiassú RM, Moura Brasil OF, de Souza EC. Regression of macular cavernous hemangioma with systemic infliximab. Ophthalmic Surg Lasers Imaging, 2010, 9: 1-3. DOI: 10.3928/ 15428877-20100215-34.
[16]	Alsulaiman SM, Abouammoh MA, Al-Dahmash SA, et al. Is systemic infliximab therapy effective for retinal cavernous hemangioma? Saudi Med J, 2014, 35(9): 1127-1130.